The FDA’s recent decision to approve tofersen offers direct benefit to people living with SOD1 ALS, and offers hope to everyone else living with ALS as well. Join the team from The ALS Association to discuss the implications of this decision for the entire ALS Community.
The views and opinions expressed in this webinar do not necessarily reflect the position of NEALS.
